Fredrik Almqvist and Marta Bally have been appointed as the new Directors of UCMR, the hub for microbial infection research at Umeå University. Their forward agenda includes enhancing collaboration with clinical research and establishing Biosafety Level 3 (BSL-3) labs for both in vitro and in vivo experiments.
Umeå Biotech Incubator (UBI) is inviting academic researchers and life science companies to meet and collaborate at its new ‘Open up for Innovation’ event on the 27th of February.
“We have world-class research being conducted at Umeå University and internationally successful companies based in town. Now we’re gathering 100 bright minds under one roof to stimulate innovation”, says Andreas
The Umeå based biotech company SweTree Technologies is expanding and is currently seeking two new employees to complete a world-unique pilot for the industrial production of spruce seedlings using Somatic Embryogenesis (SE) technology. ”By 2025, the plan is to start building a factory capable of producing 20 million seedlings per year,” says CEO Christofer Rhén.
Restoring natural ecosystems in mining disturbed landscapes is a crucial yet complex process. A groundbreaking Swedish initiative, which employs moss to accelerate this restoration, is now being heralded as a potential game changer for the global mining industry. The mining companies Boliden, Copperstone Resources, LKAB, and Talga are all participating in the ‘re:moss’ project
The Swedish Defence Research Agency (FOI) is set to significantly expand its operations in Umeå this spring after announcing plans to hire around 20 new employees to the CBRN Defence and Security department. Global developments mean Sweden needs to strengthen its national defence capability – with long-term research provided by FOI playing an important role.
The Umeå based company SpinChem AB is set to play a crucial role in the "Beat-PFAS project", funded by Formas, a Swedish government research council dedicated to sustainable development, with a grant of SEK 19.9 million. The project, led by Professor Jurate Kumpiene, aims to develop an effective solution for removing and destroying PFAS from contaminated soil and water.
The response was overwhelming when Umeå Biotech Incubator launched the Quality Assurance network in Umeå this spring. The QA network brings together around 20 representatives from Life Science Umeå to exchange experiences and tackle the industry's increasingly complex quality requirements.
The in vitro diagnostics company UmanDiagnostics has gone from being a micro business to a small business. The company specializes in nerve injury markers and the Neurofilament light protein (NFL), which makes it easier to find and diagnose neurological diseases such as Multiple Sclerosis, ALS, and Alzheimer's disease.
Swedish biotech company HiloProbe has reached a significant milestone after the results of a prospective multicenter study conducted in collaboration with Umeå University and eight Swedish hospitals were published in the International Journal of Cancer. The study results show that HiloProbe's ColoNode kit improves colon cancer diagnostics and can help more patients survive.
Swedish MedTech company Mucocort plans to launch a mucosal self-absorbing patch for pain relief in people suffering from aphthous stomatitis (mouth ulcers). The interest in Mucocort patch technology has increased after the approval of a European patent. Further, the Mucocort AB minority stakeholder Aurena Laboratories steps up with additional capital and increases its ownership.
Umeå-based Medicvent has been awarded a new prestigious assignment to deliver central systems for waste gas/diathermy and its unique double mask system used in anesthesia to Högsbo Regional Hospital, which will be inaugurated in Gothenburg in 2024. "Things are going well both in Sweden and abroad. We also have a couple of new markets that we are hoping to supply", says CEO Erik Lindström.
In June, Lipigon Pharmaceuticals signed a development and licensing agreement worth nearly SEK 1 billion. Today, the Umeå-based company has relocated to a newly renovated 250 square meter facility tailored to their needs. Lipigon's CEO, Stefan K. Nilsson, views these achievements as "pivotal strides in the company's ongoing journey of growth and innovation."
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.
Tvistevägen 48C
907 36 Umeå
Sweden